PE-1
Showing 1 - 25 of >10,000
Pancreatic Exocrine Insufficiency Trial in Shanghai (Fecal pancreatic elastase 1 test)
Completed
- Pancreatic Exocrine Insufficiency
- Fecal pancreatic elastase 1 test
-
Shanghai, Shanghai, ChinaChanghai Hospital
Mar 17, 2023
Thyroid Nodule (Benign) Trial in Naples (CellFX® Percutaneous Electrode (PE) System)
Recruiting
- Thyroid Nodule (Benign)
- CellFX® Percutaneous Electrode (PE) System
-
Naples, ItalyOspedale del Mare | ASLNA1 Centro
Oct 31, 2023
Locally Advanced/Metastatic Solid Tumors Trial (PE0116&PE0105)
Not yet recruiting
- Locally Advanced/Metastatic Solid Tumors
- (no location specified)
Mar 24, 2023
Locally Advanced/Metastatic Solid Tumors Trial in Shanghai (PE0116)
Active, not recruiting
- Locally Advanced/Metastatic Solid Tumors
-
Shanghai, China复旦大学附属中山医院
Mar 23, 2023
Mydriasis Trial in Cypress (Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE), Tropicamide 1% ophthalmic solution
Completed
- Mydriasis
- Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE)
- +2 more
-
Cypress, CaliforniaWCCT
Mar 16, 2022
PE (Pre-eclampsia) High-risk Population With Gut Microbiota Dysbiosis During Their Pregnancy Trial (aspirin 100mg and probiotics
Not yet recruiting
- PE (Pre-eclampsia) High-risk Population With Gut Microbiota Dysbiosis During Their Pregnancy
- aspirin 100mg and probiotics 1 bag
- (no location specified)
Sep 21, 2022
Physical Activity, Mental Health Wellness 1, Cognitive Function 1, Social Trial in Oxford (Physical Education (PE) Programme)
Completed
- Physical Activity
- +4 more
- Physical Education (PE) Programme
-
Oxford, Oxfordshire, United KingdomOxford Brookes University
Apr 18, 2022
HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (MTP-PE/MF59, Env 2-3)
Completed
- HIV Infections
- HIV Seronegativity
- MTP-PE/MF59
- Env 2-3
-
Rochester, New York
- +2 more
Oct 28, 2021
HIV Trial in Rochester (MTP-PE/MF59, Env 2-3)
Completed
- HIV Infections
- MTP-PE/MF59
- Env 2-3
-
Rochester, New YorkUniv. of Rochester AVEG
Oct 27, 2021
Preeclampsia, Intrauterine Growth Restriction, Maternal Hypertension Trial in Worldwide (sFlt1/PlGF screening in maternal blood
Recruiting
- Preeclampsia
- +4 more
- sFlt1/PlGF screening in maternal blood at 35 to 37 weeks of gestation
-
Liège, Belgium
- +13 more
Mar 14, 2022
Mydriasis Trial in Austin, San Antonio (Tropicamide/Phenylephrine ophthalmic solution (TR/PE), Placebo)
Completed
- Mydriasis
- Tropicamide/Phenylephrine ophthalmic solution (TR/PE)
- Placebo
-
Austin, Texas
- +1 more
Mar 16, 2022
PTSD, PTSD, Anxiety Trial in Charleston (Transcranial Direct Current Stimulation (tDCS), Prolonged Exposure Therapy)
Withdrawn
- Posttraumatic Stress Disorder
- +3 more
- Transcranial Direct Current Stimulation (tDCS)
- Prolonged Exposure Therapy
-
Charleston, South CarolinaNational Crime Victim's Research & Treatment Center, Department
Sep 20, 2021
Human Immunodeficiency Virus (HIV) Trial in South Africa, Spain, United States (DRV/COBI FDC)
Recruiting
- Human Immunodeficiency Virus (HIV)
- DRV/COBI FDC
-
Atlanta, Georgia
- +5 more
Aug 2, 2022
Colorectal Cancer Metastatic Trial in Oslo (BM7PE)
Unknown status
- Colorectal Cancer Metastatic
-
Oslo, NorwayOslo University Hospital
Feb 16, 2021
COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II
Recruiting
- COVID-19
- Cardiovascular Diseases
- Angiotensin converting enzyme inhibitor
- Angiotensin II Receptor Blockers
-
Maceio, Alagoas, Brazil
- +30 more
Jan 13, 2023
Withholding Anticoagulation in Subsegmental PE Who HaveNegative
Completed
- Subsegmental (Single or Multiple) Pulmonary Embolism
-
Halifax, Nova Scotia, Canada
- +8 more
May 27, 2021
Major Depressive Disorder in the UK Using TMS Therapy
Withdrawn
- Major Depressive Disorder
- Transcranial Magnetic Stimulator
-
London, United KingdomSt Pancras Hospital
Sep 30, 2021
A Study Looking at Ultrasound Guided Biopsies for Breast Cancer
Recruiting
- Breast Cancer
- Tumour bed core biopsy
-
Basildon, Essex, United Kingdom
- +15 more
Nov 29, 2021
Outcomes for Dilated Cardiomyopathy
Recruiting
- Dilated Cardiomyopathy
- Cardiovascular Diseases
- Part 1: DCM Cohort
- Part 2: Heritable CV Diseases and Family Members
-
Leeds, United Kingdom
- +5 more
Mar 29, 2022
Chronic Hand Eczema Trial in Canada, Spain, United Kingdom (Delgocitinib, Cream vehicle)
Recruiting
- Chronic Hand Eczema
- Delgocitinib
- Cream vehicle
-
Darlinghurst, Australia
- +25 more
Dec 12, 2022
HIV Trial in Saint Louis, Rochester, Seattle (Aluminum hydroxide, Lipid A, Monophosphoryl, Lipid A, Liposome-encapsulated
Completed
- HIV Infections
- Aluminum hydroxide
- +7 more
-
Saint Louis, Missouri
- +2 more
Oct 28, 2021
Multiple Myeloma Trial in United Kingdom (Pomalidomide, Dexamethasone, Cyclophosphamide)
Active, not recruiting
- Multiple Myeloma
- Pomalidomide
- +2 more
-
Belfast, United Kingdom
- +20 more
May 24, 2022
Roles of Resilience and Vulnerability in Pregnancy and Birth
Recruiting
- Pregnancy Related
-
Brixton, United Kingdom
- +13 more
Jan 17, 2023
Kidney Transplantation in Highly Sensitized Patients Trial in United States (drug, procedure, other)
Recruiting
- Kidney Transplantation in Highly Sensitized Patients
- Imlifidase
- +5 more
-
Birmingham, Alabama
- +12 more
Jan 12, 2023
Patients With nAMD in UK Routine Clinical Practice
Recruiting
- Neovascular Age-related Macular Degeneration
- brolucizumab
-
Peterborough, Cambridgeshire, United Kingdom
- +12 more
Jul 18, 2022